|
TAF5L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.960500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.363320E-04 |
| Normal-vs-Stage2 |
5.789900E-02 |
| Normal-vs-Stage3 |
2.760100E-02 |
| Normal-vs-Stage4 |
4.830600E-01 |
| Stage1-vs-Stage2 |
6.743600E-01 |
| Stage1-vs-Stage3 |
2.365600E-01 |
| Stage1-vs-Stage4 |
2.141800E-02 |
| Stage2-vs-Stage3 |
6.860400E-01 |
| Stage2-vs-Stage4 |
2.014800E-01 |
| Stage3-vs-Stage4 |
2.340800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.261570E-03 |
| Normal-vs-AfricanAmerican |
6.262000E-02 |
| Normal-vs-Asian |
2.175700E-02 |
| Caucasian-vs-AfricanAmerican |
8.691200E-01 |
| Caucasian-vs-Asian |
4.132000E-01 |
| AfricanAmerican-vs-Asian |
5.215000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.243600E-02 |
| Normal-vs-Female |
2.38469999999102E-05 |
| Male-vs-Female |
5.978800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.002780E-01 |
| Normal-vs-Age(41-60Yrs) |
4.880200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.717510E-03 |
| Normal-vs-Age(81-100Yrs) |
4.285400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.547000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.030800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.068600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.603600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.934400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.982600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.658400E-03 |
| Normal-vs-Grade 2 |
6.26499999999419E-05 |
| Normal-vs-Grade 3 |
9.690300E-02 |
| Normal-vs-Grade 4 |
1.849630E-01 |
| Grade 1-vs-Grade 2 |
6.935800E-03 |
| Grade 1-vs-Grade 3 |
3.798200E-04 |
| Grade 1-vs-Grade 4 |
1.601330E-03 |
| Grade 2-vs-Grade 3 |
1.107660E-02 |
| Grade 2-vs-Grade 4 |
8.118300E-02 |
| Grade 3-vs-Grade 4 |
9.289400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.13959999951064E-07 |
| Normal-vs-ccB subtype |
5.794100E-02 |
| ccA subtype-vs-ccB subtype |
2.819300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.503800E-03 |
| Normal-vs-N1 |
2.583200E-01 |
| N0-vs-N1 |
6.524800E-01 |
|
|
